Are Aderans Clinical Studies Run Through the FDA?

I noticed that Aderans has started their phase 2 studies: AderansResearch.com. However, I can’t seem to find anything from the FDA clinical site regarding their study. I tried e-mailing Aderans and got no response, so I was hoping somone with more clout might be able to help. Do you know anything about this? Are they going to go through FDA procedures and oversite?

Also, I thought that Ken Washenik was legit (he’s even presenting at the AAD conference this year). But he’s associated with this project and Bosley. Any insight into this? Is this going to be something we should consider if the technology does come out?

Finally, given the new information from Histogen, I have done some research and found that there’s a concern that some people may develp tumors from stem cell therapy. Is this something we should be worried about with this new technique presented by Histogen?

Thanks for all your help!

All of your questions and insights are significant and right on. We can not force Aderans to reveal what it is doing. FDA studies in this phase are kept confidential until results are formally released.

Yes, Dr. Washenik is the medical director at Bosley, which is one of the many companies Aderans owns. Also in their portfolio of companies is Aderans Co. Ltd (wig maker), Medical Hair Restoration (another large hair clinic chain), and a variety of others across the globe (see Aderans Group).

The concept of tumors produced by stem cells has been published in many articles over the years and you can research this on Google.